Research - News
The Kaul Foundation gives UAB $7 million to establish the Hugh Kaul Personalized Medicine Institute.
Hear from a panel of experts about the use of mobile phone apps and other mobile technology at this Feb. 9 event at the Edge of Chaos.
Assistant professor of epidemiology to discuss work in Nigeria as part of the Sparkman Global Health Lecture Series.
In a New England Journal of Medicine editorial, UAB expert Michael Saag, M.D., says a better understanding of stigma and behavior are needed for HIV prevention.
In the Diamond Microfab Lab, gem-quality diamonds are transformed into electronics that can handle everything from ocean deeps to outer space. Watch how the patented process unfolds in The Mix.
The University of Alabama at Birmingham’s Campaign for UAB: Give Something, Change Everything caps off 2014 with record-breaking December.
UAB’s research links changes in genetic regions in infants with an increased risk of premature birth — and the data change the preterm paradigm.
An interdisciplinary UAB research team hopes to learn more about how emotions might keep people from getting enough exercise.
Research to Prevent Blindness has given UAB’s Department of Ophthalmology a grant to further research of retinal and optic nerve diseases
A new study says that the cost of a medication may play a very important role in a patient’s perception of whether it works.
BCRFA continues to provide substantial gifts to UAB Cancer Center to accelerate breast cancer research.
A UAB researcher is looking for clues in the cell walls of fungi to alleviate severe fungal reactions in patients with asthma.
Together with European partners, UAB unravels basis of Singleton-Merten Syndrome, which causes heart calcification and early periodontitis.
UAB researchers receive a $1.25 million grant to identify and disseminate best management practices in nursing homes with a high census of Medicaid residents.
UAB neurology researcher Kristen Triebel gets substantial American Cancer Society grant to investigate the ability of patients to understand, choose and consent to treatment.
Precious time is lost waiting for laboratory test results for people battling this infection. With the help of medical device startup Kypha Inc., one UAB researcher’s work could change this.
Classic psychedelic drugs include LSD, psilocybin and mescaline. This new School of Public Health research is published in the Journal of Psychopharmacology.
During the past few years, technological innovations have opened up an entirely new way to approach scientific questions. Data-driven research starts with massive information sets — the genomic profiles of thousands of patients, for example, or millions of spam emails — and then searches for emerging patterns in that data. In the latest issue of the U.S. Chamber of Commerce’s "Business Horizon Quarterly", UAB President Ray Watts, M.D., explains the way data-driven research at UAB is being applied to find novel treatments for disease, create new products and businesses and train the next generation of innovation-savvy students.
The NAS will honor 25 UAB alumni-owned or alumni-operated businesses March 10; applications will be accepted through Feb. 13.
New strategies for acquiring objective data are in their infancy, and support for better tools is needed, say experts in the International Journal of Obesity.
Roadmap of early differentiation genes points to key role for dmrt1 in how the egg incubation temperature determines the sex of a hatchling.
Neuroradiologist Robert Kessler, M.D., is using UAB’s powerful cyclotron to develop imaging tests that reveal changes caused by depression, addiction, Parkinson’s disease and more.
Bartow Classic to benefit Coach Gene Bartow Fund for Cancer Research to be held 2 p.m. Saturday, Feb. 7.
Neurologist Hassan Fathallah-Shaykh, M.D., Ph.D., is deploying a new weapon in the war on cancer: mathematical theory. His sophisticated models of tumor growth are predicting new insights on cancer behavior — and could eventually guide treatment decisions. 
Technological advances are changing the way medicine is practiced, and UAB’s Department of Biomedical Engineering is working with Southern Research Institute to be at the forefront of the field.
Sixteen clinical centers and 30 hospitals will enroll up to 5,700 pregnant women to evaluate the benefits and harms of pharmacologic treatment of mild chronic hypertension in pregnancy. 
If successful, the PRESERVE-1 trial could be a significant clinical breakthrough in the treatment of the condition by prolonging pregnancy and improving outcomes. 
Innovative methods of drug discovery don’t always take place in an academic laboratory. They may start there, but they can also happen in orbit aboard the International Space Station, as protein crystallization research from UAB is about to demonstrate once again. 
A one-year, 20 percent increase in research grants elevates UAB to No. 10 among public universities receiving National Institutes of Health funding.
Women have no effect on mice, but men cause a stress level comparable to a three-minute swim. Results indicate that researchers should account for these variables.